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ABSTRACT: Ionotropic GABA receptors are widely distributed throughout the vertebrate and invertebrate
central nervous system (CNS) where they mediate inhibitory neurotransmission. One of the most widely
studied insect GABA receptors is constructed from RDL (resistance to dieldrin) subunits from Drosophila
melanogaster. The aim of this study was to determine critical features of agonists binding to RDL receptors
using in silico and experimental data. Partial atomic charges and dipole separation distances of a range of
GABA analogues were calculated, and the potency of the analogues was determined using RDL receptors
expressed in Xenopus oocytes. These data revealed functional agonists require an ammonium group and an
acidic group with an optimum separation distance of ∼5A ˚ . To determine how the agonists bind to the
receptor, a homology model of the extracellular domain was generated and agonists were docked into the
bindingsite.Thedockingstudiessupporttherequirementsforfunctionalagonistsandalsorevealedarangeof
potential interactions with binding site residues, including hydrogen bonds and cation-π interactions. We
concludethat themodel anddockingprocedures yield agood model oftheinsect GABA receptor bindingsite
and the location of agonists within it.
Ionotropic GABA
1 receptors are widely distributed through-
outthevertebrateandinvertebratecentralnervoussystem(CNS)
wheretheypredominantlymediateinhibitoryneurotransmission.
To date, three ionotropic insect GABA receptor subunits from
Drosophila melanogaster have been identified and successfully
cloned: resistance to dieldrin (RDL) (1), glycine-like receptor of
Drosophila (GRD) (2), and ligand-gated chloride channel homo-
logue 3 (LCCH3) (3). RDL is the gene product of the rdl gene,
which was identified in mutant Drosophila strains showing
resistance to the insecticide dieldrin (1). Homomeric receptors
constituted from RDL subunits (RDL receptors) are similar to
vertebrate GABAA receptors in that they are inhibited by
picrotoxin but differ in that they are not inhibited by bicuculline;
these characteristics are similar to those of GABA receptors of
cultured Drosophila neurons (4).
Cys-loop receptors, such as GABAA,G A B A C (a subclass of
GABAA), glycine, 5-HT3, and nicotinic acetylcholine (nACh)
receptors, have homologous regions that form their agonist
binding sites. These are located in the extracellular domain
and are comprised of six discontinuous loops, named A-F
(Figure 1). There are as yet no high-resolution structural data
of a complete vertebrate Cys-loop receptor, but the lower-
resolution nACh receptor structure and homologous structures,
such as those from the related acetylcholine binding protein
(AChBP),have been useful for creating homology models(5-8).
Homology models have been created for many different verte-
brate Cys-loop receptors, including nACh, 5-HT3, GABA, and
glycine receptors (9-12), but invertebrate Cys-loop receptors
have been largely ignored. The paucity of models for these
proteins is surprising, as these proteins are the targets of a
number of invertebrate specific ligands, such as insecticides,
and a better understanding of critical binding site features could
assist the development of novel, more effective compounds
(13, 14). Some information can be extrapolated from vertebrate
models,which supportpreviousmutagenesisand labelingstudies
inshowingthataromaticresiduesinthe binding loopscontribute
to the formation of an “aromatic box” that is important for
ligand binding in all of these receptors (12, 15-18). Critical
aromatic residues, however, are not necessarily equivalent for
different receptors; even in the closely related GABAA and
GABAC receptors, for example, GABA has different orienta-
tions in the binding pocket. In the former, there is a cation-π
interaction between GABA and a tyrosine residue in loop A,
while in the latter, this interaction is with a tyrosine in loop B
(12, 19). Nevertheless, in both these receptors, there is evidence
that the carboxylate residue is close to arginine residues in loop
D( 16, 20), suggesting that GABA has broadly similar orienta-
tions in both GABA receptor binding sites.
There are a range of invertebrate Cys-loop receptors that are
activated by GABA, but as mentioned above, we know little
about the molecular details of insect GABA receptor binding
sites. The aim of this study was to identify the molecular
determinants of agonist binding and potential interactions with
binding site residues in RDL receptors, one of the best studied
classes of insect GABA receptors.
EXPERIMENTAL PROCEDURES
Oocyte Maintenance. Xenopus laevis oocyte-positive females
were purchased from NASCO (Fort Atkinson, WI) and
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maintainedaccording to standard methods (21). Harvested stage
V-VI Xenopus oocytes were washed in four changes of ND96
[96mM NaCl,2 mMKCl, 1 mM MgCl2,and5mMHEPES(pH
7.5)], defolliculated in 1.5 mg/mL collagenase type 1A for
approximately 2 h, washed again in four changes of ND96,
and stored at 17 C in ND96 containing 2.5 mM sodium
pyruvate, 50 mM gentamycin, and 0.7 mM theophylline.
Receptor Expression. RDL subunit cDNA (GenBnk acces-
sion number P25123) was subcloned from pRmHa3-RDL (22)
into the oocyte expression vector pGEMHE. cRNA was trans-
cribed in vitro from the linearized plasmid cDNA template using
the mMessage mMachine T7 transcription kit (Ambion, Austin,
TX). Stage V-VI oocytes were injected with 5 ng of cRNA, and
currents were recorded 12-72 h postinjection.
Electrophysiology.Xenopusoocyteswerevoltageclampedat
-60 mV using an OC-725 amplifier (Warner Instruments,
Hamden, CT) and Digidata 1322A. Currents were filtered at a
frequencyof1kHzandsampledat350Hz.Microelectrodeswere
madefromborosilicateglass(GC120TF-10,HarvardApparatus,
Edenbridge, Kent,U.K.) using a two-stage horizontal pull (P-87,
Sutter Instrument Co., Novato, CA) and filled with 3 M KCl.
Pipette resistances ranged from 0.5 to 1.5 MΩ. Oocytes were
perfusedwithsaline[96mMNaCl,2mMKCl,1mMMgCl2,and
5mMHEPES(pH7.4)]atarateof15mL/min.Drugapplication
was via a simple gravity-fed system calibrated to run at the
same rate.
Analysis and curve fitting were performed using Prism version
3.02 (GraphPad Software, San Diego, CA). Concentra-
tion-response data for each oocyte were normalized to the
maximum current for that oocyte. Responses were normalized
to a maximal GABA-evoked response. The mean response for a
series of oocytes was iteratively fitted to the equation I = Imin þ
(Imax - Imin)/[1 þ 10
log(EC50-[A])nH], where Imax is the maximal
response, Imin is the minimum response, [A] is the concentration
of agonist, and nH is the Hill coefficient. Significance was
calculated using a one-way ANOVA or an unpaired t test
(Prism version 3.02).
Computational Ligand Analysis. Molecular modeling was
conducted with ChemBio3D Ultra 11.0 (CambridgeSoft, Cam-
bridge, U.K.). Ligand structures were generated in the charged
zwitterionic state using ChemDraw. Ligand structures were
energy minimized using the MM2 force field, and Mulliken
charges (partial atomic charges) were calculated using the
GAMESS interface. Dipole distances were calculated using the
atomic distance tool in ChemBio3D Ultra 11.0.
Homology Modeling and Docking. The protein sequence
of the RDL subunit was aligned with the sequence of AChBP
(P58154), using FUGUE (23). A three-dimensional homology
model was generated using MODELER 6v2 (24) on the basis of
the crystal structure of AChBP at 2.7 A ˚ resolution [Protein Data
Bank (PDB) entry 1i9b]. The pentamer was generated by super-
imposition of the RDL extracellular domain onto each protomer
of AChBP and was then energy minimized using the force field
implemented in MODELER 6v2. The best model was selected
after Ramachandran plot analysis of all the generated models
using RAMPAGE (http://mordred.bioc.cam.ac.uk/∼rapper/
rampage.php) (25).
Ligand structures generated using ChemBio3D Ultra 11.0
were energy minimized using the MM2 force field. Docking of
the ligands into the RDL receptor homology model was con-
ducted using GOLD 3.0. The binding site was defined using the
RC atoms of conserved aromatics Phe206, Tyr254, and Tyr109,
with a binding site radius of 10 A ˚ . Ten genetic algorithm
runs were performed on each docking exercise, giving a total of
10 solutions for each analogue. The structures were analyzed
using the implemented GoldScore fitness function to identify
the most accurate simulation. Hydrogen bonding interactions
between ligands and binding site residues were identified
using the hydrogen bond monitor function in ViewerLite
(www.accelrys.com).
RESULTS
Functional Responses. Application of GABA to Xenopus
oocytes expressing RDL receptors elicited concentration-depen-
dent inward currents. Plotting current amplitude against a range
of GABA concentrations revealed an EC50 of 19 μM (Figure 2)
which is similar to previously published results (10-31
μM) (26-30).
A range of GABA analogues were tested for activity at RDL
receptors (Figure 3). The most potent of these were muscimol,
TACA, and isoguvacine (Table 1). THIP and β-alanine are
weaker agonists with EC50 values of 220 and 800 μM, respec-
tively, while 5-aminovaleric acid (5-AV) and taurine were very
FIGURE 1: (A) RDL extracellulardomain dimer. Extracellular loops
A-F that form the agonist binding site region in related Cys-loop
receptors are labeled. (B) Sequence alignment of extracellular
domains of RDL and homologous Cys-loop receptor subunits
(human GABAA R1, human GABAA β2, mouse 5-HT3A, and
AChBP).Article Biochemistry, Vol. 49, No. 13, 2010 2899
weakagonistswithEC50valuesof1.1and>10mM,respectively.
GHB, a GABAB receptor agonist, and 3-APP, a GABAC and
GABAB receptor antagonist, had no activating effect at RDL
receptors. Glycine, 4-AB, PABA, and tyramine also failed to
activate RDL receptors when applied at concentrations up to
10 mM. EC50 values for previously tested analogues (muscimol,
β-alanine, TACA, and isoguvacine) are close to published
values (26).
Computational Ligand Analysis. The atomic distance
between the ammonium nitrogen and the carboxylate oxygen,
or its equivalent substituent, was calculated for all ligands tested.
Comparing these data to the ligand EC50 values (Table 2)
indicates a dipole separation distance for receptor activation of
∼5A ˚ .Glycinehasadipoleseparationdistanceof2.35A ˚ andmay
be too short to activate RDL receptors, while for tyramine, the
distancewas7.94A ˚ ;thus,thismoleculemaybetoolongtofitinto
the binding site cleft. GHB and 3-APP, however, which have
dipole separation distances of 5.1 and 4.5 A ˚ , respectively, are not
agonists, while 5-AV, which has a dipole separation distance of
6.5 A ˚ , can activate receptors. These data suggest that other
factors also play a role. One of these may be charge distribution;
partial atomic charge calculations suggest there is a dependence
on the electrostatic potentials of atomic groups at either end of
the ligand. Partial atomic charges of þ0.3 at ammonium hydro-
gen atoms and -0.5 to -0.6 on carboxylate oxygen atoms were
common among the most potent ligands (Table 2). However, for
3-APP and 4-amino-1-butanol (4-AB), which do not activate
FIGURE 2: (A)Electrophysiologicaltracesshowingmaximalcurrents
elicited by agonists tested at RDL receptors: GABA (100 μM),
TACA (300 μM), isoguvacine (600 μM), β-alanine (10 mM), and
taurine (10 mM). (B) Concentration response curves showing re-
sponses elicited by GABA and analogues at wild-type RDL receptors
expressed in Xenopus oocytes: muscimol>GABA>TACA>iso-
guvacine > THIP 5-AV > β-alanine > taurine. Data are means (
SEM; n g 3.
FIGURE 3: Chemical structures of GABA analogues examined in this study.
Table 1: Parameters Derived from Concentration Response Curves
a
agonist pEC50 (μM) EC50 (μM) nH
b n
c Imax/Imax(GABA)
muscimol 5.04(0.04 9.04 2.2(0.6 5 0.87(0.03
GABA 4.72 (0.03 19.3 1.8( 0.2 19 1.0(0.06
TACA 4.44(0.02 36.7 1.8(0.2 3 1.0(0.02
isoguvacine 4.19(0.03 64.9 1.9(0.2 5 0.97(0.03
THIP 3.65 (0.10 226 2.4( 1.0 5 0.57(0.06
β-alanine 3.09(0.03 807 2.0(0.3 10 1.0 (0.03
5-AV 2.95( 0.15 1120 1.0( 0.3 4 0.85(0.1
taurine <2.0 >10000 - 3 -
GHB N/R -- - -
3-APP N/R -- - -
glycine N/R -- - -
4-AB N/R -- - -
PABA N/R -- - -
tyramine N/R -- - -
aData are means ( SEM. N/R indicates no response.
bHill coefficient.
cNumber of replicates.2900 Biochemistry, Vol. 49, No. 13, 2010 McGonigle and Lummis
receptors, the charges on phosphonic acid and hydroxyl oxygens
are-1.2and -0.4respectively.Additionally,4-ABandGHBare
not zwitterions and thus carry no formal charge, so even if their
length is close to optimal for receptor activation, their inactivity
could be attributed to the absence of charge at either end of the
ligand. The hydroxyl of GHB cannot substitute for the ammo-
nium of GABA, confirming the importance of this group for
ligand binding at RDL receptors.
HomologyModelingandDocking. Homologymodelingof
the extracellular domain of RDL was based on the crystal
structure of AChBP, and analogue docking was ranked on the
basis of the GOLDscore fitness function, which ranks simula-
tions by comparing interaction energies by consideration of
predictedprotein-ligandhydrogenbondenergy,protein-ligand
van der Waals energy, ligand internal van der Waals energy, and
ligand torsional strain energy, and has been established as an
accurate method for scoring ligand-protein docking (31). The
most favored orientation for GABA in the binding site was with
theligandinthecleftamongloopsB-D(Figure4).Thecarboxyl
groupofGABA was deepestinthe cleft, located closetoresidues
Tyr109 and Arg111 in loop D. The ammonium was located
between aromatic residues contributed by loop B (Phe206) and
loop C (Tyr254), suggesting a cation-π interaction with one or
both of these residues. A hydrogen bond was predicted between
the ammonium of GABA and the backbone carbonyl of Ser205.
5-AV docked in a similar orientation with a hydrogen bond
predicted at the same location.
β-Alanine was found to dock in two almost equally favored
orientations. One of these was similar to the orientation of
GABA described above, with the carboxyl deep in the cleft and
the ammonium sandwiched between Phe206 and Tyr254. In this
orientation, there was a hydrogen bond between the ligand
ammonium and the Ser205 backbone carbonyl oxygen. In the
second orientation, β-alanine was close to Ser131 above loop E,
and there was a hydrogen bond between the ligand ammonium
and the side chain hydroxyl.
Allotheragonistsdockedwiththeammoniummoietyoriented
closetoloopBresiduesGlu204andSer205,withhydrogenbonds
predicted between these residues and TACA and taurine
(Table 3). Muscimol and isoguvacine were predicted to form
hydrogen bonds with residues Leu249 and Tyr254, respectively.
These orientations also position the carboxylatemoieties close to
loop D residue Arg111.
DISCUSSION
In this study, we have examined the characteristics of agonist
binding in RDL receptors, GABA-gated chloride selective Cys-
loop receptors found in insect nervous systems. They are
Table 2: Dipole Separation Distances of GABA Analogues
a
ligand potency pEC50 dipole separation (A ˚ ) carboxylate oxygens
b ammonium hydrogens
muscimol 5.04 5.22 -0.26 (isoxazole N), -0.47 0.32, 0.32, 0.30
GABA 4.72 4.83 -0.60, -0.54 0.31, 0.31, 0.29
TACA 4.44 4.88 -0.57, -0.53 0.31, 0.31, 0.29
isoguvacine 4.19 4.86 -0.55, -0.53 0.29, 0.31, 0.29
THIP 3.65 5.14 -0.25 (isoxazole N), -0.46 0.29, 0.31, 0.31
β-alanine 3.09 4.37 -0.58, -0.51 0.29, 0.29, 0.29
5-AV 3.06 6.47 -0.61, -0.56 0.31, 0.31, 0.30
taurine <2.0 4.46 -1.11, -1.12 0.30, 0.30, 0.28
GHB NR
d 5.10 -0.61, -0.61 -0.38 (hydroxyl O)
c
3-APP NR 4.50 -1.23, -1.23 (phosphate O) 0.29, 0.31, 0.31
glycine NR 2.35 -0.47, -0.57 0.32, 0.32, 0.27
4-AB NR 6.20 -0.38 (hydroxyl O) 0.19, 0.20, 0.24
PABA NR 6.39 -0.54, -0.54 0.30, 0.30, 0.30
tyramine NR 7.94 -0.47 (hydroxyl O) 0.31, 0.30, 0.30
aMulliken charges of GABA analogues calculated using the GAMESS interface. Ammonium hydrogens and carboxylate oxygens, or their equivalent
substituents for the dipole, are listed.
bLigands without carboxyl groups were assessed by their equivalent groups: isoxazole nitrogens in THIP and muscimol,
phosphate oxygen in 3-APP, and hydroxyl oxygen in 4-AB and tyramine.
cGHB does not have an ammonium group. The charge on the hydroxyl oxygen is
negative.
dNR=no response.
FIGURE 4: Docking of GABA and active analogues (β-alanine,
TACA, 5-AV, taurine, isoguvacine, muscimol, and THIP) into the
RDL binding site. Analogues docked with the ammonium group
locateddeepinthecleft formedbetweenloopB and loopCaromatic
residues. The carboxylate moiety or equivalent substituent was
predicted to be located facing toward Arg111.Article Biochemistry, Vol. 49, No. 13, 2010 2901
importanttounderstandasinsecticidaltargets,andknowledgeof
their structure and function could clarify how these receptors
function in other species. Here we have created a homology
model of the RDL binding site and demonstrated that GABA
and a range of GABA analogues can dock into this site with a
range ofpotentialinteractionwithbinding siteresidues. We have
also examined the characteristics of the agonists and, using
functional and modeling data, described the critical features
required to activate these receptors.
The GABA-gated chloride channels produced when RDL
subunits are expressed in Xenopus oocytes have similarities to
GABA-activated receptors in vertebrates but have distinct phar-
macologicalcharacteristics.TheyareactivatedbyGABAwithan
EC50 of ∼20 μM, exhibit minimal desensitization, can be
inhibited by PTX but not by bicuculline, and can be activated
by the GABAA receptor agonist muscimol and the GABAC
receptor agonist TACA. Muscimol, which is a full agonist of
GABAAreceptorsandapartialagonistofGABACreceptors,isa
full agonist of RDL receptors, while THIP, which is a full
agonist of GABAA receptors and an antagonist of GABAC
receptors,isa partial agonistofRDL receptors. Thesecharacter-
istics are similar to those in cockroach neurons as previously
reported (32, 33). Other GABA-gated channels that have
been heterologously expressed include those from Musca
(MdRdl) and Laodelphax where similar characteristics (e.g.,
GABA EC50 values) have been observed; some or all of these
characteristics have also been observed for GABA-gated
chloride channels in lobster, cockroach, and crab neurons and
areincontrasttothoseofGABA-gatedcationchannelsthathave
been identified in Caenorhabditis elegans,s m a l lc r a b ,a n d
Drosophila (34-38).
Our examination of the GABA agonists suggests that GABA
activates RDL receptors in the extended conformation, with
an optimum length of ∼5A ˚ . This is similar to the extended
conformation of GABA at GABAC receptors, but differs from
the partially folded conformation of GABA at GABAA recep-
tors (39, 40). 5-AV, which is one CH2 group longer than GABA,
and β-alanine, which is one CH2 group shorter, can also activate
the receptors, suggesting that they are both close enough in size
to generate essential contacts within the binding site, although
the potencies of both these compounds (EC50 ∼ 1m M )a r e
considerably weaker than that of GABA. Glycine, which is two
CH2 groups smaller than GABA, is inactive, as is tyramine,
which isconsiderablylarger thanGABA.Similarly, a correlation
between agonist affinity and agonist length has been previously
shown in GABAA receptors (39).
A carboxylate group at one end of the molecule is critical;
replacement with a hydroxyl, as in 4-AB, results in an inactive
ligand, suggesting the requirement for an anionic group at this
point of the ligand. Taurine, which is an analogue of β-alanine
with the carboxylate replaced with a sulfonate, can also act as an
agonist, although its low potency indicates that sulfonate does
not substitute very effectively for carboxylate. Replacement of
the carboxylate with a phosphoric acid group, however, as in
3-APP, results in an inactive ligand, demonstrating that the type
of acidic group is important. These data are therefore in contrast
to GABAC receptor data, where replacement of the carboxylic
acidgroupofGABAwithaphosphonicacid,phosphinicacid,or
sulfonic group produces potent antagonists (40).
The ammonium group is also critical. GHB, the well-known
“date rape” drug, is an analogue of GABA with the ammonium
group replaced with a hydroxyl. This compound had no activity
at RDL receptors.
The data therefore support the requirement for a charged
dipole for receptor activation, suggesting electrostatic interac-
tions with binding site residues are important. Computational
ligand calculations reveal a partial negative charge at the
carboxylate moiety and a partial positive charge at the ammo-
niummoietyforallactiveagonists.Thus,sinceligandsmusthave
a dipole distance close to 5 A ˚ , and both ends of the ligand are
thought to interact with the receptor, we can assume that the
agonistbindingsiteliesatthecleftbetweenthebindingloopswith
a distance from one another of ∼5A ˚ . This suggests that loops
B-D comprise the part of the binding site with which agonists
interact in this receptor, as placement of ligands between the
other loops would require a longer ligand. This hypothesis is
supported by the model which shows that loops B-Df o r ma
clearly defined pocket in which the ligands bind (Figure 1).
Docking of ligands identified several residues with hydrogen
bonding potential, in particular in loops B and C, which have
been shown to have important contact points for ligands in
5-HT3, nACh, glycine, and GABAC receptors (10, 11, 18, 19).
Most of the agonists (GABA, β-alanine, TACA, and taurine)
could form a hydrogen bond with Ser205 (loop B), and TACA
and taurine could also form H-bonds with Glu204 (also loop B).
Muscimol and isoguvacine could form H-bonds with loop C
residues Leu249 and Tyr254, respectively.
The ammonium group of all the functional agonists docked
between loop B and loop C aromatics (Phe206 and Tyr254,
respectively), suggesting a cation-π interaction. All Cys-loop
receptors studied to date have been shown to have a cation-π
interaction with an aromatic residue in the binding pocket and
the ammonium of their natural ligand, although the location of
the interacting residue varies from receptor to receptor. Such
interactions have mostly been with loop B aromatics (in nACh,
5-HT3,g l y c i n e ,a n dG A B A C receptors), but interactions with
loopC(MOD-1)andloopA(GABAA)aromaticshavealsobeen
reported (12, 41).
In conclusion, we have identified the charge and dipole
requirements for agonist recognition in RDL receptors and have
identifiedresidueswithinloopB,loopC,andloopDwhichcould
interact with agonists. We have also shown that loop B and/or
loop C aromatic residues could contribute to the binding and/or
function of the receptor via a cation-π interaction. The data
therefore provide a model of the agonist binding site, which
can be used for further structure-activity studies and rational
drug design.
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